Lck Inhibitor
CAS: 213743-31-8
Ref. 3D-NIA74331
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Información del producto
- 7-Cyclopentyl-5-(4-phenoxy)phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamine
- 7H-pyrrolo[2,3-d]pyrimidin-4-amine, 7-cyclopentyl-5-(4-phenoxyphenyl)-
- Kin 001-51
- Rk 24466
Lck inhibitor is a small-molecule drug that inhibits the enzyme Lck, which is a tyrosine kinase. It has been shown to be effective in reducing inflammation and preventing the formation of atherosclerotic plaques by inhibiting the activation of cells that promote inflammation and the production of inflammatory mediators. Dasatinib has also been shown to inhibit human CD4+ T-cells, hydrogen bond formation, and kinase selectivity. This drug is selective for Lck over other tyrosine kinases, such as Bcr/Abl or Src family members.
Dasatinib can be used for sample preparation before analysis with flow cytometry or immunohistochemistry because it does not interfere with these techniques. This drug is rapidly absorbed from the gastrointestinal tract after oral administration and excreted via urine. The pharmacokinetic properties of this drug are similar in humans and mice.
Propiedades químicas
Consulta técnica sobre: 3D-NIA74331 Lck Inhibitor
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
